Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity
Biological and Pharmaceutical Bulletin · 2024
DOI: 10.1248/bpb.b23-00802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Yuki Masuda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Chemistry, Kobe Pharmaceutical University. Hauptthemen laut MEDLINE: beta-Glucans, Grifola, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Chemistry, Kobe Pharmaceutical University.
Zitieren
APA
Masuda, Y., Yamashita, S., Nakayama, Y., Shimizu, R., & Konishi, M. (2024). Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00802
Vancouver
Masuda Y, Yamashita S, Nakayama Y, Shimizu R, Konishi M. Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00802
BibTeX
@article{Masuda2024,
author = {Masuda, Yuki and Yamashita, Shizuka and Nakayama, Yoshiaki and Shimizu, Ryohei and Konishi, Morichika},
title = {Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity},
journal = {Biological and Pharmaceutical Bulletin},
year = {2024},
doi = {10.1248/bpb.b23-00802}
}
EUVIMED